The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease
Open accessAbstract
The most common form of senile dementia is Alzheimer's disease (AD), which is characterized by the extracellular deposition of amyloid β-peptide (Aβ) plaques and the intracellular formation of neurofibrillary tangles (NFTs) in the cerebral cortex. Tau abnormalities are commonly observed in many neurodegenerative diseases including AD, Parkinson's disease, and Pick's disease. Interestingly, tau-mediated formation of NFTs in AD brains shows better correlation with cognitive impairment than Aβ plaque accumulation; pathological tau alone is sufficient to elicit frontotemporal dementia, but it does not cause AD. A growing amount of evidence suggests that soluble Aβ oligomers in concert with hyperphosphorylated tau (pTau) serve as the major pathogenic drivers of neurodegeneration in AD. Increased Aβ oligomers trigger neuronal dysfunction and network alternations in learning and memory circuitry prior to clinical onset of AD, leading to cognitive decline. Furthermore, accumulated damage to mitochondria in the course of aging, which is the best-known nongenetic risk factor for AD, may collaborate with soluble Aβ and pTau to induce synapse loss and cognitive impairment in AD. In this review, I summarize and discuss the current knowledge of the molecular and cellular biology of AD and also the mechanisms that underlie Aβ-mediated neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 2×
“The amyloid hypothesis proposes that deposition of A plaques in the brain is the primary cause of AD (Hardy and Higgins, 1992; Hardy and Selkoe, 2002).”
BackgroundThe cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · cited 6×
“Although there are differences in the genetic pathological causes between EO-FAD and LO-SAD, they show remarkable similarities in their pathophysiology and clinical symptoms (Bateman et al., 2011).”
BackgroundInfluentialWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Research works printed but not linked: 58
- Bai, 2015, An atomic structure of human γ-secretase, Nature, 525, 212, 10.1038/nature14892 · DOI · Paper page
- Brown, 2000, Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans, Cell, 100, 391, 10.1016/S0092-8674(00)80675-3 · DOI · Paper page
- Cai, 2001, BACE1 is the major β-secretase for generation of Aβ peptides by neurons, Nat Neurosci, 4, 233, 10.1038/85064 · DOI · Paper page
- Chasseigneaux, 2012, Functions of Aβ, sAPPα and sAPPβ : similarities and differences, J Neurochem, 120, 99, 10.1111/j.1471-4159.2011.07584.x · DOI · Paper page
- Chen, 2000, Impairment of hippocampal long-term potentiation by Alzheimer amyloid β-peptides, J Neurosci Res, 60, 65, 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q · DOI · Paper page
- Chen, 2006, TMP21 is a presenilin complex component that modulates γ-secretase but not ε-secretase activity, Nature, 440, 1208, 10.1038/nature04667 · DOI · Paper page
- Cleary, 2005, Natural oligomers of the amyloid-β protein specifically disrupt cognitive function, Nat Neurosci, 8, 79, 10.1038/nn1372 · DOI · Paper page
- Cullen, 1997, Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments, Neuroreport, 8, 3213, 10.1097/00001756-199710200-00006 · DOI · Paper page
- De Strooper, 2007, Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease, EMBO Rep, 8, 141, 10.1038/sj.embor.7400897 · DOI · Paper page
- Dineley, 2002, β-Amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytes, J Biol Chem, 277, 25056, 10.1074/jbc.M200066200 · DOI · Paper page
- Esler, 2001, A portrait of Alzheimer secretases--new features and familiar faces, Science, 293, 1449, 10.1126/science.1064638 · DOI · Paper page
- Figueiredo, 2013, Memantine rescues transient cognitive impairment caused by high-molecular-weight aβ oligomers but not the persistent impairment induced by low-molecular-weight oligomers, J Neurosci, 33, 9626, 10.1523/JNEUROSCI.0482-13.2013 · DOI · Paper page
- Furukawa, 1996, Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain, J Neurochem, 67, 1882, 10.1046/j.1471-4159.1996.67051882.x · DOI · Paper page
- Ghosal, 2009, Alzheimer’s disease-like pathological features in transgenic mice expressing the APP intracellular domain, Proc Natl Acad Sci USA, 106, 18367, 10.1073/pnas.0907652106 · DOI · Paper page
- Giliberto, 2010, Transgenic expression of the amyloid-β precursor protein-intracellular domain does not induce Alzheimer’s Disease-like traits in vivo, PLoS One, 5, e11609, 10.1371/journal.pone.0011609 · DOI
- Goedert, 2015, NEURODEGENERATION. Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein, Science, 349, 1255555, 10.1126/science.1255555 · DOI · Paper page
- Goedert, 2006, A century of Alzheimer’s disease, Science, 314, 777, 10.1126/science.1132814 · DOI · Paper page
- Grimm, 2005, Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin, Nat Cell Biol, 7, 1118, 10.1038/ncb1313 · DOI · Paper page
- Hamid, 2007, Amyloid precursor protein intracellular domain modulates cellular calcium homeostasis and ATP content, J Neurochem, 102, 1264, 10.1111/j.1471-4159.2007.04627.x · DOI
- He, 2010, Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease, Nature, 467, 95, 10.1038/nature09325 · DOI · Paper page
- Herreman, 2000, Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells, Nat Cell Biol, 2, 461, 10.1038/35017105 · DOI · Paper page
- Hong, 2017, Development of a reporter system for in vivo monitoring of γ-secretase activity in Drosophila, Mol Cells, 40, 73, 10.14348/molcells.2017.2294 · DOI
- Hsieh, 2006, AMPAR removal underlies Ab-induced synaptic depression and dendritic spine loss, Neuron, 52, 831, 10.1016/j.neuron.2006.10.035 · DOI · Paper page
- Hung, 1993, Activation of protein kinase C inhibits cellular production of the amyloid β-protein, J Biol Chem, 268, 22959, 10.1016/S0021-9258(19)49409-X · DOI · Paper page
- IIhara, 1986, Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer’s disease, J Biochem, 99, 1807, 10.1093/oxfordjournals.jbchem.a135662 · DOI · Paper page
- Kandel, 2014, The molecular and systems biology of memory, Cell, 157, 163, 10.1016/j.cell.2014.03.001 · DOI · Paper page
- Klein, 1999, Neurotoxicity and oxidative damage of beta amyloid 1-42 versus beta amyloid 1-40 in the mouse cerebral cortex, Ann N Y Acad Sci, 893, 314, 10.1111/j.1749-6632.1999.tb07845.x · DOI
- Knott, 2008, Mitochondrial fragmentation in neurodegeneration, Nat Rev Neurosci, 9, 505, 10.1038/nrn2417 · DOI · Paper page
- Kosik, 1986, Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease, Proc Natl Acad Sci USA, 83, 4044, 10.1073/pnas.83.11.4044 · DOI · Paper page
- Lambert, 2011, Genetics of Alzheimer’s disease: new evidences for an old hypothesis? Curr, Opin Genet Dev, 21, 295, 10.1016/j.gde.2011.02.002 · DOI
- Leissring, 2002, A physiologic signaling role for the γ-secretase-derived intracellular fragment of APP, Proc Natl Acad Sci USA, 99, 4697, 10.1073/pnas.072033799 · DOI · Paper page
- Li, 2009, Soluble oligomers of amyloid b protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake, Neuron, 62, 788, 10.1016/j.neuron.2009.05.012 · DOI · Paper page
- Lin, 1999, Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation, Proc Natl Acad Sci USA, 96, 12108, 10.1073/pnas.96.21.12108 · DOI
- McLean, 1999, Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease, Ann Neurol, 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
- Müller, 2008, The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer’s disease, Prog Neurobiol, 85, 393, 10.1016/j.pneurobio.2008.05.002 · DOI · Paper page
- Müller-Schiffmann, 2015, Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity, Brain, 139, 509, 10.1093/brain/awv355 · DOI
- Nhan, 2016, The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes, Acta Neuropathol, 129, 1, 10.1007/s00401-014-1347-2 · DOI · Paper page
- Palop, 2010, Amyloid-β-induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks, Nat Neurosci, 13, 812, 10.1038/nn.2583 · DOI · Paper page
- Palop, 2016, Network abnormalities and interneuron dysfunction in Alzheimer disease, Nat Rev Neurosci, 17, 777, 10.1038/nrn.2016.141 · DOI · Paper page
- Reddy, 2008, Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer’s disease, Trends Mol Med, 14, 45, 10.1016/j.molmed.2007.12.002 · DOI · Paper page
- Reddy, 2011, Mitochondria as a therapeutic target for aging and neurodegenerative diseases, Curr Alzheimer Res, 8, 393, 10.2174/156720511795745401 · DOI · Paper page
- Reinhard, 2005, The amyloid-β precursor protein: integrating structure with biological function, EMBO J, 24, 3996, 10.1038/sj.emboj.7600860 · DOI · Paper page
- Ryan, 2005, Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain, J Cell Biol, 171, 327, 10.1083/jcb.200505078 · DOI · Paper page
- Selkoe, 1998, The cell biology of β-amyloid precursor protein and presenilin in Alzheimer’s disease, Trends Cell Biol, 8, 447, 10.1016/S0962-8924(98)01363-4 · DOI · Paper page
- Simić, 1997, Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer’s disease, J Comp Neurol, 379, 482, 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z · DOI · Paper page
- Skovronsky, 2000, Protein kinase C-dependent α-secretase competes withβ-secretase for cleavage of amyloid-β precursor protein in the trans-Golgi network, J Biol Chem, 275, 2568, 10.1074/jbc.275.4.2568 · DOI · Paper page
- Small, 2015, Retromer in Alzheimer disease, Parkinson disease and other neurological disorders, Nat Rev Neurosci, 16, 126, 10.1038/nrn3896 · DOI · Paper page
- Strittmatter, 1993, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc Natl Acad Sci USA, 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
- Struhl, 1998, Nuclear access and action of notch in vivo, Cell, 93, 649, 10.1016/S0092-8674(00)81193-9 · DOI · Paper page
- Talantova, 2013, Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss, Proc Natl Acad Sci USA, 110, E2518, 10.1073/pnas.1306832110 · DOI · Paper page
- Terry, 1991, Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment, Ann Neurol, 30, 572, 10.1002/ana.410300410 · DOI · Paper page
- Tu, 2014, Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease, Mol Neurodegener, 9, 48, 10.1186/1750-1326-9-48 · DOI · Paper page
- Wang, 2014, FoxO mediates APP-induced AICD-dependent cell death, Cell Death Dis, 5, e1233, 10.1038/cddis.2014.196 · DOI
- Wei, 2010, Amyloid beta from axons and dendrites reduces local spine number and plasticity, Nat Neurosci, 13, 190, 10.1038/nn.2476 · DOI · Paper page
- Wirths, 2010, Neuron loss in transgenic mouse models of Alzheimer’s disease, Int J Alzheimers Dis, 2010
- Zhang, 2000, Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch–1, Nat Cell Biol, 2, 463, 10.1038/35017108 · DOI · Paper page
- Zhou, 2005, CD147 is a regulatory subunit of the γ-secretase complex in Alzheimer’s disease amyloid β-peptide production, Proc Natl Acad Sci USA, 102, 7499, 10.1073/pnas.0502768102 · DOI · Paper page
- Zhu, 2013, Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer’s disease, Alzheimers Dementia, 9, 733, 10.1016/j.jalz.2012.09.015 · DOI
Cited by
Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases
Forni, C., Facchiano, F., Bartoli, M., Pieretti, S., Facchiano, A., D’Arcangelo, D., Norelli, S., Valle, G., Nisini, R., Beninati, S., et al. (2019) · BioMed Research International · doi:10.1155/2019/8748253 · Cited by 513
Modeling Alzheimer’s disease with iPSC-derived brain cells
Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471
Synaptic basis of Alzheimer’s disease: Focus on synaptic amyloid beta, P-tau and mitochondria
John, A., & Reddy, P. H. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101208 · Cited by 359
“In AD there is particular synapse loss in the neocortex and hippocampus (Jeong, 2017).”
BackgroundThe Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Megur, A., Baltriukienė, D., Bukelskienė, V., & Burokas, A. (2020) · Nutrients · doi:10.3390/nu13010037 · Cited by 323
Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders
Ahmad, S. B., Ali, A., Bilal, M., Rashid, S. M., Wani, A. B., Bhat, R. R., & Rehman, M. U. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01324-w · Cited by 267
Metadata
- Authors
- Jeong, S.
- Venue
- Molecules and Cells
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 40
- Issue
- 9
- Pages
- 613-620
- ISSN
- 0219-1032 (ISSN-L)
- 1016-8478
- OpenAlex
- W2967414557
- Cited by
- 233
- References
- 41
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor, 19 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease. https://app.cochat.ai/papers/10.14348/molcells.2017.0096
- The paper
- Jeong, S. (2017). Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease. Molecules and Cells. https://doi.org/10.14348/molcells.2017.0096
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.